WHO ICTRP trial
A clinical trial to study the effect of Isavuconazole in patients with…
PER-061-08 · Registro Peruano de Ensayos Clínicos (REPEC) · Not Recruiting
Key facts
| Trial ID | PER-061-08 |
|---|---|
| Public title | A clinical trial to study the effect of Isavuconazole in patients with Aspergillosis and Renal Impairment or of Patients with Invasive Fungal Disease Caused by Rare Molds, Yeasts or Dimorphic Fungi. |
| Scientific title | Open Label Study of Isavuconazole in the Treatment of Patients with Aspergillosis and Renal Impairment or of Patients with Invasive Fungal Disease Caused by Rare Molds, Yeasts or Dimorphic Fungi. |
| Primary sponsor | BASILEA PHARMACEUTICA INTERNATIONAL LTD., |
| Registry | Registro Peruano de Ensayos Clínicos (REPEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | IV |
| Countries | India;Israel;Germany;Belgium;Spain;France;Egypt;United Kindgdom;Russian Federation;Australia;South Africa;Argentina;Brazil;Canada;Chile;Mexico;United States |
| Conditions | -B44 Aspergillosis Aspergillosis;B44 ;Aspergillosis |
| Interventions | Group name:Isavuconazole Type of group;1 N° of participants:100 Intervention(s) description:A loading regimen of isavuconazole will be administered at intervals of approximately 8 hours during the first 48 hours, followed by a maintenance… |
| Registration date | Nov 13, 2008 |
| Target size | 4 |
| Secondary IDs | CTRI/2012/01/002352;EUCTR2006-005003-33-GB |
| Registry page | ins.gob.pe |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: